Center of Excellence for Biosensors and Bioengineering (CEBB)
March 1, 2025 2025-03-01 17:38Center of Excellence for Biosensors and Bioengineering (CEBB)
To generate cutting-edge research and foster innovations in the realms of biosensors and bioengineering, with a specific focus on delivering tangible medical benefits in public healthcare. The ultimate goal is to effectively translate research findings and innovative solutions into sustainable advantages for broader community.
Research & Innovation Focus
Health and Well-Being + Health
Health and Well-Being + BCG
Food & Agriculture + Health
Strategic Objectives
- To deliver cutting-edge research in sensors, biosensors, and bioengineering with international recognition.
- To research and develop innovative products in the field of medical diagnostics and healthcare, with the aim of creating economic value.
Target in 3 Years
- Research excellence and international recognition.
- Research utilization / commercialization in medicine and healthcare
Research Highlights
- Bioanalytical Methods: Paper is widely used as a bioanalytical substrate because it is inexpensive and promising for point-of-care testing in developing nations. In our group, paper is utilized in the detection of laboratory medicine, food, and environmental contaminants. Currently, the active project is paper-based devices for simultaneous red blood cell antigen testing. Other ongoing projects include the determination of NCDs biomarkers such as glucose, microalbuminuria, creatinine, and cholesterol efflux capacity.
- Sensors and Biosensors: We are currently developing new and innovative technologies for detecting and monitoring various biomarkers using nanomaterials and wireless sensing technologies, which has important implications for various fields including medicine, environmental monitoring, and agriculture. We are developing modified electrodes for electrochemical detection of various biomarkers, such as anti-cancer medications, pesticides, exosomes, and wound biomarkers, using various nanomaterials such as MXenes, MOFs, and CNTs. We are collaborating with a private company to carry out some of those projects, indicating a strong potential for practical and commercial applications of our research
- Engineered Tissues: In our research, we are actively involved in the development of biomimetic tissue constructs that closely emulate the architecture and functionality of natural organs. These sophisticated constructs function as advanced biological models, providing valuable insights into organ development, disease mechanisms, and potential therapeutic interventions. Our focus includes leveraging innovative biomaterials to promote functional regeneration, thereby opening new and promising therapeutic pathways for a diverse range of medical conditions.
Networks and Partnerships
- NANOTEC
- Mahidol University
- Colorado State University (CSU, USA)
- Lund University, Sweden
- Technical University of Denmark (DTU), Denmark
- University of Bath, UK
- Hokkaido University, Japan
- Korea Advanced Institute of Science and Technology (KAIST, South Korea)
- Graduate School of Engineering, Osaka University, Japan
